GAS5 and cancer: These findings highlight the role of GAS5 in regulating metabolic pathways critical to cancer progression and suggest its potential as a prognostic biomarker and therapeutic target, underscoring the unexplored but significant role of mitochondria-related lncRNAs in cancer onset and progression55.